Phase 2 Liver Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who fully understand the study and are willing to sign a consent form agreeing to take part.
- People aged between 18 and 75 years old.
- People who are rated as largely able to carry out daily activities with little to no limitation, based on a standard medical assessment scale (ECOG score of 0 or 1).
- People whose life expectancy is at least 12 weeks.
Who may not be able to join:
- People considered unsuitable for the trial by the doctor or researcher running the study, for any reason.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jason Wu, Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phone: +86-021-5838-2983
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
progression free survival，PFS
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.